List of works by Jun Nakamura

A case of late-onset Tourette's disorder successfully treated with aripiprazole: view from blood levels of catecholamine metabolites and brain-derived neurotrophic factor (BDNF).

scientific article published in January 2009

A case of schizophrenia with Meige syndrome induced by long-term aripiprazole successfully treated with perospirone ⬇️

scientific article published on September 16, 2010

A case with occurring adverse effects when cross-over titration from fluvoxamine to paroxetine associated with increasing the plasma fluvoxamine level in major depressive disorder

scientific article published in January 2009

A close correlation between plasma and serum levels of brain-derived neurotrophic factor (BDNF) in healthy volunteers

scientific article

Abnormal white matter integrity in the corpus callosum among smokers: tract-based spatial statistics

scientific article

Acute risperidone treatment did not increase daily cigarette consumption or plasma levels of cotinine and caffeine: a pilot study

scientific article

Adding a low dose atypical antipsychotic drug to an antidepressant induced a rapid increase of plasma brain-derived neurotrophic factor levels in patients with treatment-resistant depression

scientific article published on 11 December 2009

Addition of risperidone to sertraline improves sertraline-resistant refractory depression without influencing plasma concentrations of sertraline and desmethylsertraline

scientific article

An evaluation of polymorphisms in casein kinase 1 delta and epsilon genes in major psychiatric disorders

scientific article published on 7 September 2012

An open study of risperidone liquid in the acute phase of schizophrenia

scientific article published in June 2005

Aripiprazole altered plasma levels of brain-derived neurotrophic factor and catecholamine metabolites in first-episode untreated Japanese schizophrenia patients

scientific article

Aripiprazole improves various cognitive and behavioral impairments after traumatic brain injury: a case report

scientific article published on 14 June 2012

Association analysis of SIGMAR1 with major depressive disorder and SSRI response

scientific article published on 21 February 2010

Association between plasma nitric oxide metabolites levels and negative symptoms of schizophrenia: a pilot study

scientific article published in March 2010

Associations between baseline plasma MHPG (3-methoxy-4-hydroxyphenylglycol) levels and clinical responses with respect to milnacipran versus paroxetine treatment

scientific article

Associations between plasma levels of 3-methoxy-4-hydroxyphenylglycol (MHPG) and negative symptoms or cognitive impairments in early-stage schizophrenia

scientific article published in December 2009

Attention-deficit/hyperactivity disorder symptoms and suicidal behavior in adult psychiatric outpatients

scientific article published on 04 July 2018

Blood levels of brain-derived neurotrophic factor (BDNF) in major depressive disorder

scientific article published on January 2010

Blood levels of catecholamine metabolites and brain-derived neurotrophic factor in a case of Sydenham's chorea

scientific article published in January 2009

Brain-derived neurotrophic factor (BDNF) and mood disorder

scientific article published on November 2010

COMT Val158Met, but not BDNF Val66Met, is associated with white matter abnormalities of the temporal lobe in patients with first-episode, treatment-naïve major depressive disorder: a diffusion tensor imaging study

scientific article

Catechol-O-methyltransferase Val158Met genotype and the clinical responses to duloxetine treatment or plasma levels of 3-methoxy-4-hydroxyphenylglycol and homovanillic acid in Japanese patients with major depressive disorder

scientific article published on 3 April 2015

Changes in plasma monoamine metabolites during acute lithium intoxication

scientific article published on 01 July 2000

Clinical response to antidepressant treatment and 3-methoxy-4-hydroxyphenylglycol levels: mini review

scientific article published in July 2004

Comparison of lithium, aripiprazole and olanzapine as augmentation to paroxetine for inpatients with major depressive disorder

scientific article

Comparison of the efficacy between paroxetine and sertraline augmented with aripiprazole in patients with refractory major depressive disorder

scientific article published on 17 July 2012

Continuous decrease in serum brain-derived neurotrophic factor (BDNF) levels in a neuropsychiatric syndrome of systemic lupus erythematosus patient with organic brain changes

scientific article published on December 2008

Critical examination of a correlation between brain gamma-aminobutyric acid (GABA) concentrations and a personality trait of extroversion in healthy volunteers as measured by a 3 Tesla proton magnetic resonance spectroscopy study

scientific article published on 12 March 2010

Current smoking rate in patients with psychiatric disorders in Japan: questionnaire survey

scientific article published on 17 April 2013

Decreased Activity at the Time of Return to Work Predicts Repeated Sick Leave in Depressed Japanese Patients

scientific article published in February 2016

Determination of paroxetine in serum treated with simple pretreatment by pre-column high-performance liquid chromatography using 4-(5,6-dimethoxy-2-phthalimidinyl)-2-methoxyphenylsulfonyl chloride as a fluorescent labeling reagent

scientific article

Different patterns of longitudinal changes in plasma levels of catecholamine metabolites and brain-derived neurotrophic factor after administration of atypical antipsychotics in first episode untreated schizophrenic patients

scientific article published in March 2010

Does subjective sleep quality improve by a walking intervention? A real-world study in a Japanese workplace

scientific article published on 24 October 2016

Duloxetine, a Selective Noradrenaline Reuptake Inhibitor, Increased Plasma Levels of 3-Methoxy-4-hydroxyphenylglycol but Not Homovanillic Acid in Patients with Major Depressive Disorder

scientific article published on 24 April 2014

Effect of blonanserin on cognitive and social function in acute phase Japanese schizophrenia compared with risperidone

scientific article published on 26 March 2014

Effect of latitude on suicide rates in Japan

scientific article published on 01 December 2002

Effect of prolonged exposure to milnacipran on norepinephrine transporter in cultured bovine adrenal medullary cells

scientific article

Effect of risperidone on plasma catecholamine metabolites and brain-derived neurotrophic factor in patients with bipolar disorders

scientific article published in October 2006

Effects of acute paroxetine treatment on the consumption of cigarette smoking and caffeine in depressed patients

scientific article published on 01 October 2007

Effects of antidepressants on plasma metabolites of nitric oxide in major depressive disorder: comparison between milnacipran and paroxetine

scientific article published on 5 August 2009

Effects of olanzapine on plasma levels of catecholamine metabolites, cytokines, and brain-derived neurotrophic factor in schizophrenic patients

scientific article published in January 2007

Effects of paroxetine or milnacipran on serum brain-derived neurotrophic factor in depressed patients

scientific article

Effects of repeated milnacipran administration on brain serotonergic and noradrenergic functions in healthy volunteers

scientific article published on 8 July 2006

Effects of zotepine and olanzapine on noradrenaline transporter in cultured bovine adrenal medullary cells

scientific article

Efficacy of electroconvulsive therapy is associated with changing blood levels of homovanillic acid and brain-derived neurotrophic factor (BDNF) in refractory depressed patients: a pilot study

scientific article

Fluctuating plasma levels of the active moiety of risperidone is related to occurrence of extrapyramidal symptoms

scientific article published on 01 January 2009

Follow-up Study on Electroconvulsive Therapy in Treatment-resistant Depressed Patients after Remission: A Chart Review

scientific article published on 24 April 2013

Further evidence of an association between a genetic variant in BMP7 and treatment response to SSRIs in major depressive disorder

scientific article

GTP cyclohydrolase 1 gene haplotypes as predictors of SSRI response in Japanese patients with major depressive disorder

scientific article published on 6 July 2012

Genetic overlap between antipsychotic response and susceptibility to schizophrenia.

scientific article published in February 2015

Grapefruit juice alters plasma sertraline levels after single ingestion of sertraline in healthy volunteers

scientific article published in January 2009

Grapefruit juice-fluvoxamine interaction--is it risky or not?

scientific article (publication date: August 2003)

Gray and white matter volumetric and diffusion tensor imaging (DTI) analyses in the early stage of first-episode schizophrenia

scientific article published on 24 October 2009

HTR2A is associated with SSRI response in major depressive disorder in a Japanese cohort

scientific article published on 24 November 2009

Herbal medicine (Shakuyaku-kanzo-to) improves olanzapine-associated hyperprolactinemia: a case report

scientific article published on 01 February 2013

Higher plasma 5-hydroxyindoleacetic acid levels are associated with SSRI-induced nausea

scientific article published in January 2003

Higher plasma interleukin-6 (IL-6) level is associated with SSRI- or SNRI-refractory depression

scientific article published on 28 March 2009

Identification of novel candidate genes for treatment response to risperidone and susceptibility for schizophrenia: integrated analysis among pharmacogenomics, mouse expression, and genetic case-control association approaches

scientific article published on 22 October 2009

Increase of plasma brain-derived neurotrophic factor levels in two psychotic depressed patients responding to lithium addition to paroxetine treatment.

scientific article published on January 2007

Interaction between fluvoxamine and cotinine or caffeine

scientific article published in January 2002

Lack of association between MAGEL2 and schizophrenia and mood disorders in the Japanese population

scientific article published on 14 May 2010

Nicotine dependence and its molecular pharmacology

scientific article

No Association between the Response to the Addition of an Atypical Antipsychotic Drug to an SSRI or SNRI and the BDNF (Val66Met) Polymorphism in Refractory Major Depressive Disorder in Japanese Patients

scientific article published on 30 April 2012

No alterations of brain GABA after 6months of treatment with atypical antipsychotic drugs in early-stage first-episode schizophrenia ⬇️

scientific article published on August 19, 2010

No association between BDNF Val66Met polymorphism and emergence of psychiatric symptoms in systemic lupus erythematosus patients

scientific article

No difference in adherence to paroxetine between depressed patients with early remission and those with late remission based on monitoring of plasma paroxetine concentrations ⬇️

scientific article published on August 1, 2010

No significant association between brain-derived neurotrophic factor gene rs6265 and cognitive function in Japanese patients with schizophrenia.

scientific article

No support for replication of the genetic variants identified by a recent mega-analysis of the treatment response to antidepressants.

scientific article

Nonadherence to paroxetine: a study based on monitoring plasma paroxetine levels

scientific article published in February 2010

Olanzapine orally disintegrating tablets (Zyprexa Zydis) rapidly improve excitement components in the acute phase of first-episode schizophrenic patients: an open-label prospective study

scientific article published on January 2009

Opposite effects of milnacipran, a serotonin norepinephrine reuptake inhibitor, on the levels of nitric oxide and brain-derived neurotrophic factor in mouse brain cortex

scientific article published on 6 November 2009

Pharmacogenetic study of serotonin 6 receptor gene with antidepressant response in major depressive disorder in the Japanese population

scientific article published on August 2010

Plasma catecholamine metabolite levels and the activities of psychiatric symptoms in systemic lupus erythematosus

scientific article published in March 2013

Plasma levels of 3-methoxy-4-hydroxyphenylglycol are associated with microstructural changes within the cerebellum in the early stage of first-episode schizophrenia: a longitudinal VBM study

scientific article published on 8 December 2014

Plasma levels of brain derived-neurotrophic factor and catecholamine metabolites are increased during active phase of psychotic symptoms in CNS lupus: a case report

scientific article

Plasma levels of brain-derived neurotrophic factor and interleukin-6 in patients with dysthymic disorder: comparison with age- and sex-matched major depressed patients and healthy controls

scientific article published in November 2010

Plasma levels of homovanillic acid and the response to risperidone in first episode untreated acute schizophrenia

scientific article published in March 2003

Plasma levels of interleukin-6 and selective serotonin reuptake inhibitor response in patients with major depressive disorder

scientific article published on 30 June 2013

Plasma levels of metabolites of catecholamine in nicotine-dependent patients treated with varenicline

scientific article published on 17 October 2011

Possible association between ubiquitin-specific peptidase 46 gene and major depressive disorders in the Japanese population

scientific article published on 12 June 2011

Possible relationships between plasma carbamazepine-10,11-epoxide levels and antimanic efficacy and side effects in patients with schizoaffective disorde

scientific article published on 01 June 2000

Prediction of response to risperidone treatment with respect to plasma concencentrations of risperidone, catecholamine metabolites, and polymorphism of cytochrome P450 2D6.

scientific article

Predictive factors for responding to sertraline treatment: views from plasma catecholamine metabolites and serotonin transporter polymorphism

scientific article published on 13 October 2009

Prescription pattern of antipsychotic drugs for schizophrenic inpatients in Japan: research on East Asia Psychotropic Prescription Pattern-Antipsychotics study

scientific article published on 01 December 2006

RELATIONSHIP BETWEEN THE CORTICAL THICKNESS AND SERUM CORTISOL LEVELS IN DRUG-NAÏVE, FIRST-EPISODE PATIENTS WITH MAJOR DEPRESSIVE DISORDER: A SURFACE-BASED MORPHOMETRIC STUDY.

scientific article

Rapid response to paroxetine is associated with plasma paroxetine levels at 4 but not 8 weeks of treatment, and is independent of serotonin transporter promoter polymorphism in Japanese depressed patients.

scientific article published in August 2009

Reduction of brain gamma-aminobutyric acid (GABA) concentrations in early-stage schizophrenia patients: 3T Proton MRS study.

scientific article

Relationship between G1287A of the NET Gene Polymorphisms and Brain Volume in Major Depressive Disorder: A Voxel-Based MRI Study

scientific article

Relationship between a BDNF gene polymorphism and the brain volume in treatment-naive patients with major depressive disorder: A VBM analysis of brain MRI.

scientific article published on 30 May 2015

Relationship between the catechol-O-methyl transferase Val108/158Met genotype and brain volume in treatment-naive major depressive disorder: Voxel-based morphometry analysis

scientific article published on 31 July 2015

Relationship between white matter integrity and serum cortisol levels in drug-naive patients with major depressive disorder: diffusion tensor imaging study using tract-based spatial statistics

scientific article published on 18 February 2016

Relationships between brain-derived neurotrophic factor, clinical symptoms, and decision-making in chronic schizophrenia: data from the Iowa Gambling Task

scientific article

Relationships between serum brain-derived neurotrophic factor, plasma catecholamine metabolites, cytokines, cognitive function and clinical symptoms in Japanese patients with chronic schizophrenia treated with atypical antipsychotic monotherapy

scientific article published on 13 July 2016

Relationships between stress, social adaptation, personality traits, brain-derived neurotrophic factor and 3-methoxy-4-hydroxyphenylglycol plasma concentrations in employees at a publishing company in Japan ⬇️

scientific article published on September 15, 2010

Reliability, validity and clinical utility of a Japanese version of the Social Adaptation Self-evaluation Scale as calibrated using the Beck Depression Inventory

scientific article published in December 2011

Risk factors for further sick leave among Japanese workers returning to work after an episode of major depressive disorder: a prospective follow-up study over 1 year

scientific article published on 11 September 2019

Risperidone in the treatment of psychotic depression

scientific article published on 06 March 2006

SIRT1 gene is associated with major depressive disorder in the Japanese population

scientific article published on 7 May 2010

Serotonin 6 receptor gene and mood disorders: case-control study and meta-analysis

scientific article published on 13 April 2010

Serum Levels of Brain-Derived Neurotrophic Factor at 4 Weeks and Response to Treatment with SSRIs.

scientific article published on 21 January 2014

Serum brain-derived neurotrophic factor levels as a novel biological marker for the activities of psychiatric symptoms in systemic lupus erythematosus

scientific article published in March 2010

Serum brain-derived neurotrophic factor levels at 6 months after remission are not associated with subsequent depressive episodes

scientific article published in February 2013

Serum levels of brain-derived neurotrophic factor (BDNF), BDNF gene Val66Met polymorphism, or plasma catecholamine metabolites, and response to mirtazapine in Japanese patients with major depressive disorder (MDD).

scientific article published on 10 August 2012

Serum levels of brain-derived neurotrophic factor (BDNF), proBDNF and plasma 3-methoxy-4-hydroxyphenylglycol levels in chronic schizophrenia

scientific article published on 14 January 2016

Serum levels of brain-derived neurotrophic factor in comorbidity of depression and alcohol dependence.

scientific article published in July 2009

Serum proBDNF/BDNF and response to fluvoxamine in drug-naïve first-episode major depressive disorder patients.

scientific article

Several prescription patterns of antipsychotic drugs influence cognitive functions in Japanese chronic schizophrenia patients

scientific article published on 05 December 2011

Six-month treatment with atypical antipsychotic drugs decreased frontal-lobe levels of glutamate plus glutamine in early-stage first-episode schizophrenia

scientific article published on 3 April 2012

Steroid psychosis in a polyarteritis nodosa patient successfully treated with risperidone: tracking serum brain-derived neurotrophic factor levels longitudinally

scientific article published on 23 January 2012

Stimulation of catecholamine synthesis via activation of p44/42 MAPK in cultured bovine adrenal medullary cells by milnacipran

scientific article published on 09 January 2007

Stress at work alters serum brain-derived neurotrophic factor (BDNF) levels and plasma 3-methoxy-4-hydroxyphenylglycol (MHPG) levels in healthy volunteers: BDNF and MHPG as possible biological markers of mental stress?

scientific article published on 17 November 2007

Successful treatment for obsessive-compulsive disorder with addition of low-dose risperidone to fluvoxamine: implications for plasma levels of catecholamine metabolites and serum brain-derived neurotrophic factor levels

scientific article published in June 2006

Switching to antipsychotic monotherapy can improve attention and processing speed, and social activity in chronic schizophrenia patients

scientific article

The CLOCK gene and mood disorders: a case-control study and meta-analysis

scientific article published in November 2011

The brain-derived neurotrophic factor (BDNF) polymorphism Val66Met is associated with neither serum BDNF level nor response to selective serotonin reuptake inhibitors in depressed Japanese patients

scientific article published on 19 February 2011

The case of a depressed man who exhibited hyperprolactinemia and galactopoiesis after electroconvulsive therapy

scientific article published in March 2012

The cognitive profile of aripiprazole differs from that of other atypical antipsychotics in schizophrenia patients

scientific article published on 29 March 2012

The effects of a walking intervention on depressive feelings and social adaptation in healthy workers.

scientific article published in March 2013

The serotonin 1A receptor gene confer susceptibility to mood disorders: results from an extended meta-analysis of patients with major depression and bipolar disorder

scientific article published on 03 July 2012

The valproate serum level in maintenance therapy for bipolar disorder in Japan

scientific article published in March 2013

Therapeutic drug monitoring of plasma fluvoxamine levels for treating bulimia nervosa

scientific article published on 01 August 2007

Three polymorphisms of the eNOS gene and plasma levels of metabolites of nitric oxide in depressed Japanese patients: a preliminary report

scientific article published in October 2011

Treatment with risperidone for 4 weeks increased plasma 3-methoxy-4-hydroxypnenylglycol (MHPG) levels, but did not alter plasma brain-derived neurotrophic factor (BDNF) levels in schizophrenic patients

scientific article

Trichotilliomania responding to low-dose fluvoxamine

scientific article published in October 2009

Two cases of burning mouth syndrome treated with olanzapine

scientific article published in June 2008

Type A behavior pattern and hyperthymic temperament: possible association with bipolar IV disorder

scientific article published on 31 May 2011

Varenicline does not increase serum BDNF levels in patients with nicotine dependence

scientific article published in April 2010

Variants of dopamine and serotonin candidate genes as predictors of response to risperidone treatment in first-episode schizophrenia

scientific article

[Double depression]

scientific article published on 01 January 2003

[Effects of smoking and caffeine on pharmacological treatment for patients with schizophrenia and depression]

scientific article published on 01 December 2011

[Review of pharmacological efficacies and side effects of antidepressants]

scientific article published on 01 September 2007

[Role of Psychiatry in Occupational Health: Focus on Stress Check System in Japan]

scientific article published on 01 January 2017

[Therapeutic effectiveness of transcranial magnetic stimulation for intractable depressive disorders-- blood catecholamines and BDNF]

scientific article published on 01 January 2007

Paulina is supported by:

About Paulina

Help